Hyoscyamine Sulfate Oral Tablet, Biphasic Release 0.375Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Hyoscyamine Sulfate: Oral tablet, biphasic release (0.375mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_8366.JPG
Symax Duotab 0.125mg-0.250mg
Capellon Pharmaceuticals Inc
Pill Identification: SYMAX  |  DUOTAB
Drug Image file DrugItem_14547.JPG
HyoMax-DT 0.375mg Tab
Aristos Pharmaceuticals, Inc
Pill Identification: 8762 
Drug Image file DrugItem_11179.JPG
Hyoscyamine IR/SR Biphasic Tab
Rivers Edge Pharmaceuticals
Pill Identification: RE 251 

What is this Medicine?

HYOSCYAMINE (hye oh SYE a meen) is used to treat stomach and bladder problems. This medicine is also used for rhinitis, to reduce some problems caused by Parkinson's disease, and for the treatment of poisoning with drugs that are usually used to treat myasthenia gravis.

In-Depth Information
Select a Medication

HyoMax-DT 0.375mg Biphasic-Release Tablet

NDC: 244860604
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)




FDA approved for the following conditions:
Irritable Bowel Syndrome, Gastric Ulcer, Duodenal Ulcer

Storage Information
Store at controlled room temperature (between 68 and 77 degrees F)
HyoMax-DT 0.375mg Biphasic-Release Tablet
Drug Image file DrugItem_14547.JPG
Aristos Pharmaceuticals, Inc
Pill Identification: 8762 
Shape: oblong
Color: purple,white
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Hyoscyamine Sulfate

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.